Medical dictionary

Medical terminology normalized via MeSH, ICD-11, SNOMED CT.

62,341 terms indexed

• C5770174-amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-5-ethynylpyrimidin-2(1H)-oneMeSH

  structure in first source

• C5772024-amino-1-(3,4-dihydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidin-2(1H)-oneMeSH

  has antiviral activity

• C5725144-amino-2,8-dichloropyrido(3,2-d)pyrimidineMeSH

  structure in first source

• C5877084-amino-2-iminopyridineMeSH

  structure in first source

• C5857454-amino-2-trifluoromethyl-phenyl retinateMeSH
• C5740254-amino-3-chlorophenyl hydrogen sulfateMeSH

  a metabolite of resatorvid; structure in first source

• C5767164-amino-3-hydroxynapthalene-2-sulfonic acidMeSH

  structure in first source

• C5683714-amino-3-methyl-2-oxoazepane-4-carboxylateMeSH

  structure in first source

• C5788214-amino-6-(2'-amino-4'-hydroxyphenyl)-3-hydroxy-2-methyl-6-oxohexanoic acidMeSH

  structure in first source

• C5598984-amino-6-bromo-1-(3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-pyrrolo(2,3-d)pyrimidine-5-carboxamideMeSH

  BMK-Y101 is the (2S,3S,4S,5S)-isomer; antineoplastic agent that inhibits both Cdk7 and Cdk9; structure in first source

• C5815674-amino-6-hydroxy-2-mercaptopyrimidineMeSH

  a capping ligand for gold nanoparticles used in the determination of tannic acid

• C5782634-amino-6-phenylamino-2-methoxy-5-nitrosopyrimidineMeSH

  has antifungal activity; structure in first source

• C5844634-amino-8-(2,5-dimethoxyphenyl)-N-propylcinnoline-3-carboxamideMeSH

  structure in first source

• C5762374-amino-8-(2-fluoro-6-methoxy-phenyl)-N-propylcinnoline-3-carboxamideMeSH

  a GABA(A) alpha2,3 receptor modulator; structure in first source

• C5736414-amino-N-(thiazol-2-yl)benzenesulfonamideMeSH

  has antibacterial activity; structure in first source

• C5754194-aminobenzaldehydeMeSH

  a yellow colorimetric indicator for detecting fluoride; structure in first source

• C5699104-aminobenzimidazole-1-methylthymineMeSH

  structure in first source

• C5881354-aminophenylbenzoxazol-2-yl-5-acetic acidMeSH

  structure in first source

• C5699794-aminophthalazin-1(2H)-oneMeSH

  structure in first source

• C5722344-aminopyridinium maleateMeSH

  structure in first source

• C5842844-aminopyrrolopyrimidineMeSH

  structure in first source

• C5737754-aminoquinazolineMeSH

  structure in first source

• C5778814-azahexacyclo(5.4.1.0(2,6).0(3,10).0(5,9).0(8,11))dodecan-3-olMeSH

  structure in first source

• C5708024-azetidinyl-7-nitrobenz-2-oxa-1,3-diazoleMeSH

  structure in first source

• C5717394-azidophenyl fenpyroximateMeSH

  structure in first source

• C5842824-azolylphenyl isoxazolineMeSH

  structure in first source

• C5693594-benzoyl-1-(4-methyl-imidazol-5-yl)carbonylthiosemicarbazideMeSH

  has antibacterial activity; structure in first source

• C5819754-benzoyl-2-nitrophenyl thiocyanateMeSH

  inhibits resuscitation-promoting factor B from Mycobacterium tuberculosis; structure in first source

• C5833724-benzyl-3-((1-methylpyrrol-2-yl)methyl)-4,5-dihydro-1H-1,2,4-triazol-5-oneMeSH

  structure in first source

• C5687194-benzyloxyphenyl-(2-thienyl)iodonium bromideMeSH

  structure in first source

• C5830784-bromo-2,5-dimethoxyphenylacetic acidMeSH

  urinary metabolite of the hallucinogen 4-bromo-2,5-dimethoxyphenethylamine; structure in first source

• C5830804-bromo-2,5-dimethoxyphenylethyl alcoholMeSH

  urinary metabolite of the hallucinogen 4-bromo-2,5-dimethoxyphenethylamine; structure in first source

• C5844784-bromo-2-(piperidin-1-yl)thiazol-5-yl-phenyl methanoneMeSH

  structure ijn first source

• C5830794-bromo-2-hydroxy-5-methoxyphenylacetic acidMeSH

  urinary metabolite of the hallucinogen 4-bromo-2,5-dimethoxyphenethylamine; structure in first source

• C5833424-bromo-2-methoxyphenolMeSH

  structure in first source

• C5822244-bromo-4'-dimethylamino benzylideneanilineMeSH

  structure in first source

• C5785114-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-oneMeSH

  reverses antibiotic resistance in persister cells of Pseudomonas aeruginosa; structure in first source

• C5822214-bromo-N,N-5,5-dimethyl-2,5-dihydro-1,2-oxaphosphol-2-amine-2-oxideMeSH
• C5606264-bromo-N-(1-(2,4-difluoro-phenyl)ethyl)-2-(quinoxaline-5-sulfonylamino)benzamideMeSH

  structure in first source

• C5692614-bromo-N-(5-ethyl-5H-pyrido(4,3-b)indol-8-yl)benzenesulfonamideMeSH

  structure in first source

• C5623584-butoxyethoxy-N-octadecyl-1,8-naphthalimideMeSH

  a fluorescent probe for protein determination; structure in first source

• C5695064-butyl-11-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-(1,3)dioxolo(4,5-c)phenanthridin-5(4H)-oneMeSH

  has antiviral activity against hepatitis C virus; structure in first source

• C5695054-butyl-11-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-7-methoxy-(1,3)dioxolo(4,5-c)phenanthridin-5(4H)-oneMeSH

  has antiviral activity against hepatitis C virus; structure in first source

• C5834704-carboxybenzenesulfonamide-chitosanMeSH

  structure in first source

• C5731894-carboxypyrazoleMeSH
• C5714804-chloro-2-(trifluoromethyl)anilineMeSH

  structure in first source

• C5622394-chloro-3-(4-cyclopropylbenzyl)-1-(xylopyranosyl)-1H-indoleMeSH

  inhibits sodium-dependent glucose cotransporter 2 (SGLT2); structure in first source

• C5694454-chloro-4'-chlorobenzylidene anilineMeSH

  structure in first source

• C5781144-chloro-5-(2-(4-(6-fluoro-benzo(d)isoxazol-3-yl)-piperidin-1-yl)-ethyl-amino)-2-methyl-2H-pyridazin-3-oneMeSH

  structure in first source

• C5851414-chloro-N'-thieno(2,3-d)pyrimidin-4-ylbenzenesulfonohydrazideMeSH

  structure in first source